We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+11.71%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$461B
AUM Growth
+$24.9B
Cap. Flow
-$12.1B
Cap. Flow %
-2.62%
Top 10 Hldgs %
40.03%
Holding
5,800
New
615
Increased
1,596
Reduced
2,751
Closed
340

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.34B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.65B
3
TSLA icon
Tesla
TSLA
+$1.45B
4
QQQ icon
Invesco QQQ Trust
QQQ
+$1.01B
5
AAPL icon
Apple
AAPL
+$833M

Sector Composition

Rank Sector Weight
1 Technology 20.48%
2 Financials 7.27%
3 Consumer Discretionary 6.82%
4 Communication Services 5.06%
5 Healthcare 4.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GMAB icon
5126
Genmab
GMAB
$19.2B
$153 ﹤0.01%
5
-5,001
-100% -$122K
RNXT icon
5127
RenovoRx
RNXT
$52.3M
$150 ﹤0.01%
+118
New +$140
ALGS icon
5128
Aligos Therapeutics
ALGS
$47.8M
$147 ﹤0.01%
+15
New +$137
PETS icon
5129
PetMed Express
PETS
$42.1M
$143 ﹤0.01%
+57
New +$176
LPBBW
5130
Launch Two Acquisition Corp Warrant
LPBBW
$3.33M
$142 ﹤0.01%
390
NXTS
5131
Nexentis Technologies
NXTS
$2.73M
$134 ﹤0.01%
+5
New +$271
FTHM icon
5132
Fathom Holdings
FTHM
$24M
$130 ﹤0.01%
72
NTRB icon
5133
Nutriband
NTRB
$38.2M
$127 ﹤0.01%
+18
New +$131
BCAB icon
5134
BioAtla
BCAB
$5.76M
$126 ﹤0.01%
+4
New +$92
TCRT icon
5135
Alaunos Therapeutics
TCRT
$4.84M
$121 ﹤0.01%
50
-50
-50% -$143
LEE icon
5136
Lee Enterprises
LEE
$181M
$120 ﹤0.01%
+22
New +$114
FORA
5137
DELISTED
Forian
FORA
$117 ﹤0.01%
+52
New +$106
MLTX icon
5138
MoonLake Immunotherapeutics
MLTX
$1.47B
$115 ﹤0.01%
16
-4,537
-100% -$236K
MURA
5139
DELISTED
Mural Oncology
MURA
$114 ﹤0.01%
55
+51
+1,275% +$110
OESX icon
5140
Orion Energy Systems
OESX
$78.3M
$114 ﹤0.01%
+13
New +$91
FDSB
5141
Fifth District Bancorp
FDSB
$94.2M
$111 ﹤0.01%
+8
New +$107
MPTI.WS
5142
DELISTED
M-tron Industries Warrants
MPTI.WS
$111 ﹤0.01%
63
CRD.B icon
5143
Crawford & Co Class B
CRD.B
$588M
$108 ﹤0.01%
+11
New +$112
SGRP
5144
DELISTED
SPAR Group
SGRP
$108 ﹤0.01%
+105
New +$117
NCL icon
5145
Northann Corp
NCL
$102 ﹤0.01%
+99
New +$127
PDYNW icon
5146
Palladyne AI Corp Warrants
PDYNW
$169K
$100 ﹤0.01%
500
HYFM icon
5147
Hydrofarm Holdings
HYFM
$9.29M
$98 ﹤0.01%
+30
New +$119
ADVM
5148
DELISTED
Adverum Biotechnologies
ADVM
$96 ﹤0.01%
+21
New +$62
ELSE
5149
DELISTED
Electro-Sensors
ELSE
$96 ﹤0.01%
+20
New +$94
NMFC icon
5150
New Mountain Finance
NMFC
$726M
$96 ﹤0.01%
+10
New +$104

Similar funds

Barclays's Q3 2025 Portfolio in Review

As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
  • Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
  • Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
  • Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
  • Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
  • Barclays opened 615 new positions and closed 340 in Q3 2025.
  • Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.

Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.